| Period Ending | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 |
|---|
|
Total Revenue
|
160,232
|
161,855
|
146,997
|
133,996
| | Cost of Revenue | 75,235 | 71,310 | 63,393 | 65,508 | | |
Gross Profit
|
84,997
|
90,545
|
83,604
|
68,488
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 34,916 | 36,093 | 36,476 | 42,881 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 3,359 | 3,296 | 3,295 | 3,051 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
46,722
|
51,156
|
43,833
|
22,556
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 4 | 3 | 2 | (5,395) |
|
Earnings Before Interest And Taxes | 46,726 | 51,159 | 43,835 | 17,161 |
|
Interest Expense | 26,665 | 19,663 | 19,850 | 16,361 |
|
Income Before Tax | 20,061 | 31,496 | 23,985 | 800 |
|
Income Tax Expense | 7,804 | 12,252 | 9,330 | 815 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 12,257 | 19,244 | 14,655 | (15) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
12,257
|
19,244
|
14,655
|
(15)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
12,257
|
19,244
|
14,655
|
(15)
|
|
0.06(0.20%) 2:34PM EDT - Nasdaq Real Time Price